4D Molecular Therapeutics, Inc. Common Stock
$14.47
▼ 0.24
(-1.63%)
Volume: 1,017,950
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
54
- 21d momentum -7.0%
- MA aligned bullish
- RSI 52
🎯
Pullback
50
- -0.1% vs 20MA
💎
Value
50
- No fundamental data
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)51.9
MACD-0.050
MA trendBullish
ATR6.89%
21d mom.-7.0%
63d mom.+24.7%
vs 20MA-0.1%
RVOL(20)1.12×
52w low · 7
52w high · 17
-14.5% from 52-week high
20d support 13
· resistance 16
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$813M
PER—
PBR1.99
PSR8.83
EPS$-3.24
ROE-44.0%
ROA-36.4%
Dividend yield0.00%
Debt/Equity0.05
EV/EBITDA-3.97
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| -4.93% | -7.01% | +24.74% | +42.14% | +71.45% | +97.68% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum -3.34%, daily vol 5.32%. 4D Molecular Therapeutics, Inc. Common Stock sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.